{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":25,"n_cols":5,"rows_kept":25,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[13,2,13,3],[14,2,14,3],[15,2,15,3],[17,2,17,3],[18,2,18,3],[22,2,22,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910455348403321"]
[null,null,"Titolo",null,"Hormones, cognition and dementia : state of the art and emergent therapeutic strategies / / edited by Eef Hogervorst [and others] [[electronic resource]]"]
[null,null,"Pubbl/distr/stampa",null,"Cambridge : , : Cambridge University Press, , 2009"]
[null,null,"ISBN",null,"1-107-21241-3"]
[{"$nulls":4},"0-511-69990-5"]
[{"$nulls":4},"1-282-33693-2"]
[{"$nulls":4},"9786612336935"]
[{"$nulls":4},"0-511-63481-1"]
[{"$nulls":4},"0-511-63526-5"]
[{"$nulls":4},"0-511-63315-7"]
[{"$nulls":4},"0-511-63194-4"]
[{"$nulls":4},"0-511-63570-2"]
[{"$nulls":4},"0-511-63436-6"]
[null,null,"Descrizione fisica",null,"1 online resource (xii, 280 pages) : digital, PDF file(s)"]
[null,null,"Disciplina",null,"616.8/3"]
[null,null,"Soggetti",null,"Dementia - Prevention"]
[{"$nulls":4},"Estrogen - Therapeutic use"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Title from publisher's bibliographic system (viewed on 05 Oct 2015)."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Estrogens and cognition: perspectives and opportunities in the wake of Women's Health Initiative Memory Study -- Women's Health Initiative Memory Study (WHIMS) program: emerging findings -- Identifying risk factors for cognitive change in the Women's Health Initiative: a neural networks approach -- Estrogen therapy: relationship to longevity and prevalent dementia in the oldest-old: the Leisure World Cohort Study and the 90+ Study -- Critical window hypothesis: hormone exposures and cognitive outcomes after menopause -- Animal studies that support estrogen effects on cognitive performance and the cholinergic basis of the critical period hypothesis -- Healthy cell bias of estrogen action through regulating glucose metabolism and mitochondrial function: implications for prevention of Alzheimer's disease -- Varieties of estrogenic therapy -- Alternative estrogenic treatment regimens and the Kronos Early Estrogen Prevention Study: Cognitive and Affective "]
[{"$nulls":4},"substudy (KEEPS-CA) -- Use of transdermal 17-estradiol in the treatment of Alzheimer's disease -- Alternative modes of treatment: pulsatile estradiol treatment -- In search of estrogen alternatives for the brain -- Potential modulators and modifiers of estrogenic effects -- Progesterone regulation of neuroprotective estrogen actions -- Clinical data of estrogen's effects in the central nervous system: estrogen and mood -- Different forms of soy processing may determine the positive or negative impact on cognitive function of Indonesian elderly -- Hypothalamus-pituitary-adrenal axis activity in aging women: its impact on the brain and the potential influence of estradiol -- Possible genetic factors related to hormone treatment effects -- Possible genetic polymorphisms related to sex steroid metabolism and dementia in women -- Genetics related to sex steroids: implications for Alzheimer's disease -- Apolipoprotein E, hormone therapy, and neuroprotection -- Testosterone, gonadotropins, and genetic polymorphisms in men with Alzheimer's disease -- Testosterone, estradiol and men, and sex hormone binding globulin -- Androgens and cognitive functioning in women -- Role of estradiol in testosterone treatment -- Endogenous testosterone levels and cognitive aging in men -- Clinical trials and neuroimaging studies of testosterone in men: insights into effects on verbal memory -- Testosterone therapy and Alzheimer's disease: potential for treatment and prevention in women -- Endogenous estradiol and dementia in elderly men: the roles of vascular risk, sex hormone binding globulin, and aromatase activity -- Testosterone regulates Alzheimer's disease pathogenesis -- Gonadotropin effects -- Involvement of gonadotropins in cognitive function: implications for Alzheimer's disease -- Role of gonadotropins and testosterone in the regulation of beta-amyloid metabolism."]
[null,null,null,"Sommario/riassunto","A decade ago, oestrogen-containing hormone therapy was viewed as a promising strategy for the prevention and treatment of dementia and age-related cognitive decline. However, treatment trials in women with Alzheimer's disease showed that oestrogens did not reverse cognitive impairment, and clinical trials in healthy older women indicated that oestrogens did not prevent cognitive decline. The Women's Health Initiative Memory Study trial even suggested an increased risk of dementia with treatment late in life. What happened? How are we to understand these findings? What are the implications for middle-aged and older women? What about testosterone, and what about men? And where do we go from here? This book brings together world-renowned experts in basic and clinical research on sex steroids, aging, and cognition to integrate existing findings with emerging new data, and offer challenging hypotheses on these key issues."]